Complera challenges HIV market again with health insurance benefits
Janssen Korea’s HIV treatment ‘Complera’ attracted the industry as returning the market with health insurance benefits.
The Ministry of Health and Welfare(MOHW) revised and announced health insurance registration of Complera Tab(emtricitabine, rilpivirine, tenofovir disoproxil fumarate) on the 2...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.